CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Clinical trials for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC) trials appear
Sign up with your email to follow new studies for CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shrink tough skin cancers
Disease control Not yet recruitingThis study is testing whether combining two drugs, pucotenlimab and becotatug vedotin, can help control advanced skin cancer that has spread or cannot be removed by surgery. It is for patients who have few other treatment options left. The goal is to see if the combination shrink…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Blink-and-It's-Done radiation trial aims to zap skin cancer with fewer side effects
Disease control Not yet recruitingThis study is comparing a new, ultra-fast radiation treatment called FLASH therapy to standard radiation for common skin cancers. It aims to see if delivering the entire radiation dose in milliseconds, instead of minutes, can effectively treat the cancer while causing fewer side …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: PHASE2 • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Could a simple scan make skin cancer surgery more precise?
Diagnosis Not yet recruitingThis study is testing if using a special high-frequency ultrasound scan before surgery helps doctors better map out skin cancers on the face, head, or neck. The goal is to see if this extra scan helps surgeons remove the entire tumor in one go, reducing the need for repeat surger…
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC
-
Vitamin B3 cream trial offers hope to stop skin cancer in High-Risk transplant patients
Prevention Not yet recruitingThis study is testing whether applying a cream containing 5% niacinamide (a form of vitamin B3) daily can help prevent skin cancer in people who have received an organ transplant. Organ transplant recipients take medications that weaken their immune system, which makes them much …
Matched conditions: CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
Phase: EARLY_PHASE1 • Sponsor: Marissa Lobl • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC